Target intelligence / Profile preview

Polyunsaturated fatty acid (PUFA)

Target
PUFA
Molecular classification
Other (Lipid; Fatty Acid)
01

Overview

Polyunsaturated fatty acids (PUFAs) are long-chain hydrocarbon molecules containing two or more double bonds in their structure. The most biologically significant subclasses include omega‑3 (n‑3) and omega‑6 (n‑6) families. These double bonds introduce kinks into the molecule—especially when present in the cis configuration—resulting in increased membrane fluidity compared with saturated fats. PUFAs play essential roles as structural components of cell membranes, precursors for bioactive lipids such as prostaglandins and leukotrienes, regulators of inflammation and immunity, modulators of cardiovascular health by reducing triglycerides and inhibiting platelet aggregation, among other functions. While they have important physiological benefits when consumed at appropriate ratios through diet or supplements like fish oil/icosapent ethyl, excessive intake can pose safety risks such as increased bleeding tendency due to their antiplatelet properties.

Other names
PUFAsOmega-3 fatty acid (a subclass)Omega-6 fatty acid (a subclass)n-3 polyunsaturated fatty acidn-6 polyunsaturated fatty acid
02

Mechanism of action

For drugs like icosapent ethyl: Supplementation increases plasma levels of EPA, which can reduce triglyceride synthesis, inhibit platelet aggregation, decrease inflammation by altering eicosanoid production from arachidonic acid to less inflammatory forms derived from EPA/DHA. PUFAs act as: Substrates for cyclooxygenase/lipoxygenase pathways to generate bioactive lipid mediators. Structural modulators in membranes affecting protein function.

03

Biological functions

Maintenance of cell membrane fluidityPrecursor for prostaglandin and eicosanoid synthesisModulation of inflammation and immune responseRegulation of cardiovascular function (e.g., antiarrhythmic effects)
04

Disease associations

Cardiovascular disease (protective roles via omega‑3 PUFAs)Inflammation-related diseasesReproductive health/fertility issues
05

Safety considerations

High doses (>3g/day) may increase bleeding risk due to antiplatelet effects.Other concerns include potential oxidative stress if balance with antioxidants is inadequate due to susceptibility to lipid peroxidation.
06

Interacting drugs

Icosapent ethyl (prescription EPA)
07

Biomarkers

Plasma/serum levels of omega‑3 index or specific PUFAs may be used to monitor dietary intake or cardiovascular risk.

Beyond the preview

Go deeper on Polyunsaturated fatty acid (PUFA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polyunsaturated fatty acid (PUFA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call